Calidi Biotherapeutics 2024 Antitumor Virotherapies Presentation

Calidi Biotherapeutics presents its systemic and localized antitumor virotherapy platform designed to harness the immune system against cancer. The presentation outlines the company's engineered allogeneic stem cell product candidates and development progress toward clinical trials. Calidi is an immuno-oncology company developing novel immunotherapy approaches with partnerships including Northwestern University and City of Hope.